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Immunization is a proven tool for controlling and eliminating life-threatening infectious diseases and is estimated to avert between 2 and 3 million deaths each year. It is one 
of the most cost-effective health investments, with proven 
strategies [1]. Significant advances in child health have resulted 
from the conduct of various drug and vaccine trials in pediatric 
age group. Well-known trials of polio vaccine and the subsequent 
rapid translation into practice were instrumental in the successful 
and almost complete eradication of polio [2,3]. The new vaccines 
are still being developed, tested in clinical trials, and brought into 
routine clinical practice.
The enrollment of children into clinical trials is challenging 
due to relatively small number of available participants. This 
is further complicated by the challenges of obtaining parental 
consent for the child to participate [4]. The slow recruitment can 
lead to prolonged study duration, increased resource use, and 
increased budget or premature termination of recruitment which 
can result in underpowered studies.
Studies have shown that parents balance risks and benefits 
when deciding about trial participation for their child [5,6]. Kong 
et al. have reported that the perceived barriers for clinical trial 
participation include potential side effects, being randomized to 
ineffective treatments, mistrust of the health-care system, and the 
inconvenience for visits [7].
India is increasingly recognized as a site for clinical research 
due to its large population and growing research capabilities, though 
data regarding barriers for recruitment into pediatric vaccine clinical 
trials are scarce. The present study was carried out to assess barriers 
in recruitment and to assess parental factors for non-participation 
of their babies in the vaccine clinical trial. This would help us in 
planning strategies for improving recruitment in future studies.
MATERIALS AND METHODS
This study was a prospective cross-sectional non-interventional 
study which was carried out in the pediatric clinical research 
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unit of a tertiary care multispecialty teaching hospital in Pune. 
The study was conducted from June 2018 to December 2018 
when enrollment of babies aged 6–8 weeks old in a phase-four 
pneumococcal vaccine trial was carried out in the pediatric 
clinical research unit. The study was initiated after approval from 
the institutional ethics committee.
The study social worker visited postnatal ward to prime 
mothers regarding the pneumococcal vaccine clinical trial. 
She telephonically called parents of eligible babies to remind 
them to bring their babies for vaccination to our hospital once 
the baby was 6 weeks old (n=384). Few parents could not be 
reached, as they did not pick up phone or number was not 
reachable, few parents told that they were going outstation, few 
had taken vaccine outside, and few of them said that they would 
come, but did not come. Thus, of 384 inborn babies, only 148 
parents brought their babies to clinical research unit.
Outpatient department (OPD) pediatricians were informed 
of the ongoing pneumococcal vaccine clinical trial and were 
requested to refer 6–8-week-old healthy babies to the clinical 
research unit. Babies, who were brought to the unit for the study 
recruitment, underwent screening for inclusion/exclusion criteria 
of the vaccine trial by the study physician. Babies who did not 
fulfill these criteria were excluded from the study and were 
referred back to OPD pediatrician for checkup and vaccination. 
The parents of eligible babies were explained the informed consent 
form of this clinical trial and their willingness for participation 
was sought (n=204).
The reason for refusal of the parents was documented and 
they were advised to take routine vaccination in the OPD 
(n=110). Thus, our study cohort included 148 inborn (our 
hospital deliveries) and 56 outborn babies (babies born in another 
hospital).
Statistical analysis was done using SPSS software with 
version 25.0. All qualitative variables were represented by 
frequency and percentages. Chi-square test was used to study the 
association between different variables in the study. Throughout 
results, 5% level of significance was used and all results were 
shown with 95% of confidence.
RESULTS
Flowchart of babies presented to clinical research unit for 
counseling and its outcome:
M: Male babies, F: Female babies, N: Number of babies.
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The flowchart above shows that of 384 eligible inborn babies, 
only 148 (38.54%) babies were brought to clinical research unit 
and 84 babies of this cohort were enrolled in the study. Regarding 
outborn babies, only 10 of 56 (17.86%) babies were enrolled in 
the study. There was no gender difference noted in enrolled versus 
non-enrolled babies [Table 1].
The majority of enrolled babies were inborn (89.36%). There 
was no significant association between baby’s gender and place 
of delivery.
Unwillingness for participation in clinical trial was the major 
reason for non-enrollment (68.18%) both in inborn and outborn 
babies. The association between non-enrollment and place of 
delivery of babies was not clinically significant [Table 2].
DISCUSSION
Clinical trials are considered the gold standard for generating 
evidence-based knowledge in medicine. Successful recruitment 
in pediatric clinical trials is one of the most challenging aspects of 
conducting clinical research in children. This study was carried out to 
evaluate recruitment barriers and to assess parental reasons for non-
participation of 6–8-week-old babies in the vaccine clinical trial.
Our study has shown that even though eligible inborn baby 
pool was large (n=384), only 148 (38.54%) inborn babies were 
brought to our clinical research unit, thus a major barrier in 
recruitment. Vanhelst et al. have reported that Lasagna’s law, 
i.e., the “number of patients in the predictive pool always exceed 
those eligible, which again exceeds those who consent during 
the recruitment period of the study” might have a greater impact 
on pediatric studies [8]. Thoma et al. have also reported that 
investigators greatly overestimate the pool of available patients 
who meet the inclusion criteria [9].
In this study, 94 of 204 (46.08%) babies were enrolled which 
were lesser than our previous study which had shown that 52% of 
parents were willing to enroll their babies in clinical trials [10]. 
Higher participation rate of 64.5% is reported by Gupta et al. [11], 
but the study by Vanhelst et al. has demonstrated only 32% of 
participation rate among healthy children as compared to 93% 
among ambulatory sick children [8].
The study shows that out of the babies who presented to 
clinical research unit for counseling for the clinical trial and 
enrolled in the study, 84/94 (89.36%) were inborn. This is 
probably due to the priming in the postnatal ward, reminder 
phone calls, and faith in the hospital/hospital physicians. 
Faith in doctor/hospital and doctor’s influence are  important 
reasons for enrollment in clinical trials as seen in various 
studies [4,12,13]. Hoberman et al. have observed that 
positive parental perception of the researcher is associated 
with greater likelihood to consent [12]. Good relationships 
and communication between parents and their clinician offer 
parents a sense of understanding, safety, and trust, as reported 
by Shilling and Young [13]. Unger et al. have reported that 
the physicians play a key role in helping patients, determine 
treatment choice, and patients often look to their physicians to 
inform them of clinical trials [14]. Thus, the parents of inborn 
babies are more likely to get enrolled as compared to outborn 
babies as seen in our study.
In this study, 56/204 (27.45%) babies were outborn and out of 
these, only 10/56 (17.86%) babies could be recruited in the study. 
The lower recruitment of outborn babies might be due to multiple 
factors such as lack of rapport with the parents or they were 
unaware of the clinical trials and had not come prepared, had no 
time for study procedures, and had concerns about research and 
its safety.
Various reasons for non-participation in clinical trials have 
been reported in earlier studies. Limkakeng et al. have shown 
that mistrust of researchers is a near-universal barrier to research 
participation across cultures [15]. Greenberg et al. have shown 
that for the study recruitment, contact from a “stranger” was much 
less preferred [4]. It has been reported that parents are unlikely to 
consent if they are not convinced by the study team that their 
children could benefit from being in the study [4,16]. Shilling 
and Young reported that parents of healthy children considering 
participation in vaccine research believed that children should 
only take part in research where the medical benefits outweigh 
any potential risk [13]. Vanhelst et al. have stated that the main 
improvement factor for enrollment was that the investigators 
should devote more time to parents, discussing pediatric clinical 
Table 1: Babies enrolled in the study
Inborn/outborn Male (n) Female (n) Total (%) Chi‑square value p‑value
Inborn 48 36 84 (89.36) 0.185 0.667
Outborn 5 5 10 (10.64)
Total 53 41 94 (100)
Table 2: Reasons for non‑enrollment of babies
Reason for non‑enrollment Inborn babies (%) Outborn babies (%) Total number (%) Chi‑square p‑value
Not willing 42 (65.63) 33 (71.74) 75 (68.18) 12.28 0.423
Going outstation/stay far off 17 (26.56) 7 (15.22) 24 (21.82)
Lack of time 2 (3.13) 3 (6.52) 5 (4.55)
Because its research 2 (3.13) 3 (6.52) 5 (4.55)
Other babyies had ventricular septal defect 1 (1.56) 00 1 (0.90)
Total 64 (58.18) 46 (41.82) 110 (100)
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research studies [8]. Hence, to facilitate enrollment of outborn 
babies, we would have to establish good rapport with parents and 
rigorous counseling needs to be reinforced.
We did not observe any significant gender difference in 
clinical trial enrolment, i.e., 53 (56.38%) were male babies, in 
contrast to our earlier study which had shown that the parents 
were more likely to give consent for clinical trial participation 
for girl child [10]. Parents who refused study participation of 
their baby were asked reasons for non-enrollment, but most 
of the parents (68.18%) did not specify any particular reason 
for their unwillingness. The second most common reason for 
non-participation of babies was, going outstation and staying far 
away from our hospital. As per the prevailing custom in our state 
to have first delivery at maternal place, the mothers travel to and 
from their maternal house post-delivery, thus not available for 
entire study duration, poses an important sociocultural barrier for 
recruitment of 6–8-week-old babies.
Lack of time for the study procedures was another reason for 
declining enrollment by 5 (4.55%) parents as also shown in the 
previous studies [9,17]. There was concern about the research 
vaccine of 5 (4.55%) parents and so they did not enroll their 
babies in the study. Shah et al. have reported potential participants 
voicing their concerns about safety procedures as well as possible 
side effects and health risks [18]. Fear and uncertainty about new 
drugs and mistrust of system are reported as a barrier by Kong 
et al. [7]. Vanhelst et al. have shown that safety was the main 
concern for the parents of healthy children [8]. Fear of potential 
risks and a general distrust in research are also reported by Tromp 
et al. [19]. Our study was limited by its small sample size and also 
it was limited to only one clinical research site.
CONCLUSION
Our study has shown that only 38.54% of inborn babies were 
brought to our clinical research unit, thus a major barrier in 
recruitment which shows that Lasagna’s law holds true for 
recruitment of babies in clinical trial. The inborn babies are more 
likely to come for counseling of vaccine clinical trial and get 
enrolled, as compared to outborn babies. The major reason for 
non-enrollment was “unwillingness” for participation in clinical 
trial. More effective counseling and recruitment strategies are 
needed to scale up the enrollment more so for the outborn babies.
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